|Bid||38.11 x 900|
|Ask||39.76 x 900|
|Day's Range||38.48 - 38.70|
|52 Week Range||34.29 - 46.10|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||37.65|
|Forward Dividend & Yield||0.75 (1.95%)|
|Ex-Dividend Date||Apr 05, 2021|
|1y Target Est||49.50|
Smith & Nephew (LON:SN.) has had a rough three months with its share price down 14%. We, however decided to study the...
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a marketing collaboration with Movendo Technology (Genoa, Italy) that will add personalised robotic patient rehabilitation capability to Smith+Nephew's Real Intelligence enabling technology solutions, creating a fully digitised patient pathway from the pre-op stage to post-rehab phase. The collaboration has launched in Europe and will expand to other regions in the near future.